In this issue:
 |
|
Upcoming Events |
The UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (UCSF-Stanford CERSI) is holding the third annual Innovations in Regulatory Science Summit, a gathering of leaders in the academia, industry, and regulatory sectors to discuss the role of regulatory science in medical product development.
Panels include:
- Issues and Opportunities Generated by Accelerated Approval: Confirmatory Endpoints, Evidence Generation, and Value
- Biomarkers and Surrogate Endpoints: Alzheimer’s as a Prototype
- Pandemic and Beyond: The Future of the FDA (Featuring former FDA commissioners)
Attend on Sunday, Jan. 9, 2022 at 8:00 a.m. Pacific
 
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is hosting a Technology to Improve Maternal Health workshop on January 18 at noon. This workshop will bring together small businesses, academia, and community partners to review the state of technology in maternal health in an effort to reduce maternal morbidity and mortality in the U.S. and improve maternal health.
Tune in on Tuesday, Jan. 18, 2022 at 12:00 p.m. ET
The National Heart, Lung, and Blood Institute's (NHLBI) Small Business Program is partnering with the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) for a three-part webinar series examining medical device innovation with regulatory science tools.
Who should attend:
- Entrepreneurs
- Small business innovators who are interested in using regulatory science tools for emerging technologies
Hear from distinguished leaders in the small business and med tech innovation space including NHLBI, CDRH, and the Small business Education and Entrepreneurial Development (SEED) office.
Attend Wednesday, Jan. 19, 2022 at 1:00 p.m. ET
Join the National Institute on Aging (NIA) and National Heart, Lung, and Blood Institute (NHLBI) Small Business Programs on Tuesday, January 25, 2022, at 3 p.m. ET for Investment Funding I: Finding the Right Investor, part of the Entrepreneur Workshop Series.
In part one of this two-part workshop, the NIA and NHLBI Small Business Programs will cover a variety of topics related to seeking and obtaining an investment.
Topics include:
- Dilutive versus non-dilutive funding
- Types of investors and investment capital
- Cap tables and term sheets
Tune in on Tuesday, Jan. 25, 2022 at 3:00pm ET
 |
|
Funding Opportunities |
The NIH I-Corps™ program provides participants with hands-on training from experienced industry professionals to help transition from researcher to entrepreneur on a path towards commercialization. Past participants have used lessons learned at I-Corps at NIH to write strong Phase II applications, win partnerships and investments, and build a wide network in the field.
DEADLINE: TODAY, Dec. 15 at 5:00 p.m. your local time
SBIR and STTR grant funding opportunities offer small business entrepreneurs a chance to obtain non-dilutive funding for early-stage research and development. Applications are accepted three times a year. The next receipt date is Wednesday, January 5, 2022. Remember to use Forms-F for this application cycle.
DEADLINE: Jan. 5, 2022
NHLBI seeks former small business (SBIR/STTR phase II) awardees to apply for bridge funding for projects that address rare diseases or young pediatric populations. The goal is to help move projects through regulatory approvals and into commercialization by promoting partnerships with investors and/or patient advocacy organizations. Attend an informational webinar on Jan. 19, 2022 to learn more.
Earliest submission date: January 28, 2022
NHLBI seeks former small business (SBIR/STTR phase II) awardees to apply for bridge funding for projects that address NHLBI’s mission. The goal is to help move projects through regulatory approvals and into commercialization by promoting partnerships with investors and/or patient advocacy organizations. Attend an informational webinar on Jan. 19, 2022 to learn more.
Earliest submission date: January 28, 2022
The National Human Genome Research Institute (NHGRI) has an open Transformative Nucleic Acid Technology Innovation and Early Development request for applications (RFA) that solicits SBIR R43/R44 grant applications to innovate and develop the early stages of novel technologies that will enable greater than a one order of magnitude improvement in 1) DNA sequencing or 2) methods for direct sequencing of the diversity of entire RNA molecules.
Next due date: Tuesday, March 1, 2022
Looking to hire new and diverse talent for your company? Apply for an administrative supplement to cover the salary of an early-career scientist from underrepresented groups in biomedical research and the biotech sector.
Find your point of contact.
View full list of active funding opportunities
|
